The Hindu Business Line : Jubilant in collaboration with Endo Pharma

MUMBAI: Drug firm Jubilant Organosys on Thursday said its subsidiary Jubilant Biosys has forged a three-year collaboration with US-based pharmaceutical firm Endo Pharmaceuticals for research in Oncology (dealing with tumours).

The Bangalore-based Jubilant Biosys has entered into a discovery and development collaboration with Endo Pharma, Jubilant Organosys said in a filing to the Bombay Stock Exchange.

“We anticipate significant rewards on successful development of compounds and its subsequent commercialisation,” Jubilant Organosys CMD, Mr Shyam S Bhartia and Co-CMD, Mr Hari S Bhartia said in the statement.

As part of the agreement, Jubilant and Endo would collaborate initially to develop a portfolio of targets in the area of oncology.

“We are excited about this opportunity with Jubilant. We look forward to our collaboration with the goal of bringing new therapies and health-care solutions to patients,” Endo Pharmaceuticals MD and Executive Vice-President (Research & Development), Mr I van Gergel said.

Endo would own any compounds developed under the collaboration and would be responsible for worldwide commercialisation. - PTI

Prev: Rupee tumbles 36 paise to 47.60/61
Next: RBI in fix to help recovery or check inflation: Report

Business Line | NUS Index |

Copyright copy; 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line